Vultaggio Vincent sold ZNTL
February 6, 2026 · Form 4 insider transaction
Vultaggio Vincent sold 29,951 shares of Zentalis Pharmaceuticals, Inc. at $2.43 per share, a transaction worth $72.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
29,951
Price
$2.43
Total value
$72.8K
InsiderVultaggio Vincent
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 6, 2026
Filing dateFebruary 10, 2026
Shares owned after156,779
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.